Amanda L Armijo Selected Research

2'-deoxycytidine 5'-triphosphate (dCTP)

3/2014	Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication.
9/2013	Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda L Armijo Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 09/2013
2	Hematologic Neoplasms (Hematological Malignancy) 11/2014 - 03/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014
1	Leukemia 03/2014

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2014
2	2'-deoxycytidine 5'-triphosphate (dCTP)IBA 03/2014 - 09/2013
1	NitrosaminesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	MethyltransferasesIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	NucleotidesIBA 03/2014
1	ThymidineIBA 03/2014
1	Deoxycytidine KinaseIBA 09/2013
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2013

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2014
1	Drug Therapy (Chemotherapy) 01/2020